CN‐105, our current apoE‐mimetic pentapeptide, retains the beneficial neuroprotective effect in ischemic stroke observed in other apoE‐mimetic peptides31, 32 and possesses increased CNS penetration and potency.35 This evidence concerns the gene APOE and ischemic stroke.